eazyplex® VRE is a ready-to-use, lyophilized in vitro diagnostic kit designed for the qualitative detection of vancomycin resistance genes.
The assay targets the main vancomycin resistance genes (vanA and vanB) in Enterococcus species, enabling rapid identification of resistant strains.
LAMP technology enables rapid and specific amplification of resistance gene targets at a constant temperature
No DNA extraction needed — simplifies the workflow
Results available in approximately 25 minutes
Real-time detection of amplification signal
Internal controls included to verify correct assay performance and help avoid false negatives
Fast turnaround time compared with culture-based screening
Simple workflow with minimal hands-on time
Direct testing from clinical swabs or cultured isolates
Lyophilized reagents ready for immediate use and stable in storage
High sensitivity and specificity for vancomycin resistance genes
The test is intended for clinical microbiology and hospital laboratories as an aid in the rapid identification of vancomycin-resistant Enterococcus (VRE) during patient screening or diagnostic workups. Early detection supports:
Infection control measures and surveillance in healthcare settings
Timely clinical decision-making and antimicrobial stewardship
Reduction of VRE transmission risk among patients
For more information, please contact us by e-mail: diagnostika@pentagen.cz
